ArticlePDF Available

Cancer Pattern among Adults in Najran, Saudi Arabia - 2014-2019

Authors:

Abstract

Background: Najran is one of the thirteen regions in Saudi Arabia, located in the southwest of the country with a recently established oncology center and cancer registry. This paper describes for the first time the incidence of cancer in this region which has a unique geographic and demographic attribute. Methodology: This is a retrospective descriptive study that included all adult (diagnosis age >14 years) cancer patients captured by Najran regional cancer registry in the period of 2014 to 2019. Available data, including demographics, diagnosis, site of the tumor, and histopathology were analyzed. Pediatric malignancies were excluded. During the studied period, a regional registry was established and linked to the central Saudi Cancer Registry. All confirmed cancer cases in Najran were captured in this registry. Results: The Total number of records was 1600 diagnosed over a 6-year period (range, 200-330 per year). More females were reported (54.6%) than males (45.4%). The median age was 52 years (SD, ±19). The three most common cancers were breast (14.2 %), thyroid (11.8%), and Colorectal (8.4%). Among the females, breast (25.3%) was the most common cancer followed by thyroid (16.7%), and colorectal (7%); while in males, colorectal cancers (10.2%), hepatocellular carcinoma (6.7%), and leukemia (6.6) were the most common. Conclusions: Breast cancer in females and colorectal cancer in males were the most frequent types of solid malignancies in Najran, Saudi Arabia. Our study shows that the pattern of cancers bears some similarities with the national and Gulf data with some differences that warrant further exploration.
International Journal of Innovative Research in Medical Science (IJIRMS)
Volume 05, Issue 10, October 2020,
https://doi.org/10.23958/ijirms/vol05-i10/979
www.ijirms.in
485
Original article
Cancer Pattern among Adults in Najran, Saudi
Arabia - 2014-2019
Ahmed M. Badheeb *, Nadeem M. Nagi, Mohamed A. Badheeb
Oncology Center, King Khalid Hospital- Najran Saudi Arabia
Corresponding Author: Prof. Ahmed M. Badheeb, MD; badheebdr@gmail.com
Received: 09 October 2020; Accepted: 23 October 2020; Published: 26 October 2020
Abstract
Background: Najran is one of the thirteen regions in Saudi Arabia, located in the southwest of the country with a recently established oncology
center and cancer registry. This paper describes for the first time the incidence of cancer in this region which has a unique geographic and
demographic attribute. Methodology: This is a retrospective descriptive study that included all adult (diagnosis age >14 years) cancer patients
captured by Najran regional cancer registry in the period of 2014 to 2019. Available data, including demographics, diagnosis, site of the tumor,
and histopathology were analyzed. Pediatric malignancies were excluded. During the studied period, a regional registry was established and
linked to the central Saudi Cancer Registry. All confirmed cancer cases in Najran were captured in this registry. Results: The Total number of
records was 1600 diagnosed over a 6-year period (range, 200-330 per year). More females were reported (54.6%) than males (45.4%). The
median age was 52 years (SD, ±19). The three most common cancers were breast (14.2 %), thyroid (11.8%), and Colorectal (8.4%). Among the
females, breast (25.3%) was the most common cancer followed by thyroid (16.7%), and colorectal (7%); while in males, colorectal cancers
(10.2%), hepatocellular carcinoma (6.7%), and leukemia (6.6) were the most common. Conclusions: Breast cancer in females and colorectal
cancer in males were the most frequent types of solid malignancies in Najran, Saudi Arabia. Our study shows that the pattern of cancers bears
some similarities with the national and Gulf data with some differences that warrant further exploration.
Keywords: Saudi Cancer Registry, Incidence, Najran, Saudi Arabia
Introduction
Cancer is a leading cause of death worldwide in countries of all
income levels. The incidence and mortality are expected to increase
rapidly as populations grow, age, and adopt lifestyle risk factors
that increase cancer risk such as tobacco use, physical inactivity,
obesity, and reproductive patterns are increasingly worldwide [1].
“In 2018, cancers accounted for over 9.6 million deaths and
there were more than 18.1 million new cases worldwide. The most
commonly diagnosed cancers worldwide are lung, breast, and
colorectal cancers. The most common causes of cancer death are
lung, stomach, and liver cancers “(The International Agency for
Research on Cancer 2018) [2].
In Saudi Arabia, breast, colorectal cancers are the
commonest type of cancers followed by the thyroid, Non-Hodgkin
lymphoma, and leukemia [3].
The aim of this paper is to describe the pattern of cancer in
Najran region and to explore the association with age, sex, and site
of cancer according to the international classification of disease
(oncology).
Materials and Methods
This is a retrospective descriptive study that included all adult
(diagnosis age >14 years) cancer patients captured by Najran
regional cancer registry in the period of 2014 - to 2019. Available
data, including demographics, diagnosis, site of tumor, and
histopathology was analyzed. Pediatric malignancies were
excluded. During the studied period, a regional registry was
established and linked to the central Saudi Cancer Registry. All
confirmed cancer cases in Najran, were captured in this registry.
The cancers were arranged according to the affected organ
to specify the most affected site in both males and females. The
data were analyzed to find percentages, means, and standard
deviations. All confirmed cancer cases that from Jan 2014 to
December 2019 were revised retrospectively. The cases identified
from the cancer registry. Demographic, clinical, and
histopathological data had been collected.
Results
The Total number of cases was 1600 for the period 2014-2019.
Cancer was more frequent in females (54.6%) than males (45.4%)
(figure1).
International Journal of Innovative Research in Medical Science (IJIRMS)
www.ijirms.in
486
Figure: Distribution of cases by sex
The median age was 52 years with a standard deviation (SD) of 19.
The three most common cancers were breast (14.2 %), thyroid
(11.8%), and Colorectal (8.4%). Among the females, breast
(25.3%) was the most common cancer followed by thyroid
(16.7%), and colorectal (7%). On the other hand, colorectal cancers
(10.2%), hepatocellular carcinoma (6.7%), and leukemia (6.6) were
the most prevalent among males. The five most common types
were breast (14.2 %), thyroid (11.8%), and Colorectal (8.4%),
gastric (4.8%), and leukemia (4.7%). (Table 1)
Table 1: The 10 Most Common Cancers
Site of Cancer
Number
% of all sites
1
Breast
228
14.2
2
Thyroid
189
11.8
3
Colorectal
135
8.4
4
Gastric
77
4.8
5
Leukemia
75
4.7
6
NHL
74
4.6
7
Liver
72
4.5
8
Head & Neck
56
3.5
9
Pancreas
55
3.4
10
Brain
53
3.3
All sites total
1600
100.0%
Regarding topographic distribution by sex, the five major cancers
in males were colorectal (10.2 %), liver (6.7), leukemia (6.6%),
NHL (6.2%), & gastric (6.1%), (Table 2), while in females, the
most common cancers were breast (25.3%), thyroid (16.7%),
colorectal (7 %), ovarian(5.8%), and gastric (3.8%) (Table:3).
Table 2: The 10 Most Common Male Cancers
Site of Cancer
1
Colorectal
2
Liver
3
LEUKEMIA
4
NHL
5
Gastric
6
THYROID
7
HEAD & NECK
8
BLADDER
9
Brain
10
Pancreatic
Table 3: The10 Most Common Female Cancers
Site of Cancer
% of all sites
1
Breast
25.3
2
THYROID
16.7
3
Colorectal
7.0
4
OVARIAN
5.8
5
Gastric
3.8
6
Uterine
3.4
7
NHL
3.3
8
LEUKEMIA
3.1
9
Hodgkin’s Lymphoma
2.7
10
Liver
2.6
Discussion
This study was performed to analyze the incidence of cancer
among adults at Najran region in Saudi Arabia constitutes of six
governorates (Najran, Sharourah, Yadama, Thar, Haboona, &
Badr-Aljanoob) with a population of 408,272 according to “2010
census” [4].
The results of our study showed that the malignancies were
more frequent in females (54.6%) than males (45.4%), and this is
similar to the National Saudi Cancer registry data were the females
(53.8%) while the males (46.2%).
The top ten cancers in this study were breast, thyroid,
colorectal, gastric, leukemia, Non-Hodgkin’s Lymphoma, liver,
head & neck, pancreas, and brain. There is a similarity in the
incidence of breast cancer (the first) & leukemia (the fifth position)
with the Saudi cancer registry 2015 and the Gulf Cooperation
Council (GCC) results [5,6].
Thyroid cancer as the fastest growing cancer in terms of its
incidence comes as the second common cancer (11.8%) which is
higher than the national (8.5%), GCC (6.3%), and the international
figures, this may be related to two factors, the first one is the
overdiagnosis by the fine needle aspiration biopsy, while the
second possible cause is the low iodine intake in Najran region as
showed in meta-analysis where a higher intake of dietary iodine
was as a protective factor against thyroid cancer [7-9].
Although our study showed a lower incidence of the
colorectal (8.4%) in comparison with the national figure of 12.2 %
we are in concordance with the GCC (9%) and the world (10%).
Gastric cancer ranked as the fourth (4.8%), while not seen
among the top 10 national cancers, but we are again in concordance
with the GCC, where the gastric cancer is the 8th one (3.4%) and
all over the world as the fifth (5.7%) [10].
The most commonly diagnosed cancer worldwide is the
lung cancer, while our study showed a low incidence of this cancer
(2.8%) mostly as a result of the lower prevalence of tobacco
smoking in Najran in contradictory to the higher prevalence of
tobacco chewing that may explain the higher incidence of head &
neck cancer (8th, 3.5%) as a unique finding differs from the local
& worldwide figures [11].
Our study showed pancreatic cancers among the top ten
with global similarity where about 338000 people had pancreatic
cancer in 2012 worldwide, making it the 11th most common
cancer. To date, the causes of pancreatic cancer are still
insufficiently known, although certain risk factors have been
identified, such as smoking, obesity, genetics, diabetes, diet,
inactivity. Our figures are higher than the national and GCC
figures, this warrants further exploration [9].
In males, the incidence of male genital system
malignancies (including prostate cancers), like other Arabian Gulf
and Asian countries, is very low compared to Western despite the
International Journal of Innovative Research in Medical Science (IJIRMS)
www.ijirms.in
487
high intake of calories and high consumption of animal fat [12-14].
This may be attributed to the lack of prostate screening programs
[15].
Conclusion
In conclusion, breast cancer in females and colorectal cancer in
males were the most frequent types of solid malignancies in
Najran, Saudi Arabia. Our results generally indicate that the pattern
of the most common registered cancer bears some similarities with
the national and Gulf data with some differences that warrant
further exploration.
Ethics approval and consent to participate
This study was conducted after approval of the Cancer Research
Committee in the oncology Department at King Khalid Hospital in
Najran. No informed consent needed for this type of study with no
extra burden for participants and anonymized data.
Data Availability
Data are available at Saudi Cancer Registry - Najran and it will be
included in the periodic report of the national registry.
Conflicts of Interest
The authors declare that there is no conflict of interest regarding
the publication of this paper.
Funding Statement
The research and publication of this article was self-funded.
Authors' contributions
AB analyzed and interpreted the patient data. NN and MB
performed were contributors in writing the manuscript. All authors
read and approved the final manuscript.
Acknowledgments
The authors would like to acknowledge Mrs. Rahma Mabkhoot at
the Saudi Cancer Registry Office, King Khalid Hospital - Najran
for her cooperation, to Dr. Iyad Sultan for reviewing the paper, and
to the colleagues in the oncology team for caring for cancer
patients and to their families.
References
[1] Torre L. A., Siegel R. L., Ward E. M., et al.: Global
Cancer Incidence and Mortality Rates and Trends--An
Update: a publication of the American Association for
Cancer Research, cosponsored by the American Society
of Preventive Oncology. Cancer Epidemiology
Biomarkers & Prevention. 2016, 25:16-27.
10.1158/1055-9965.epi-15-0578
[2] Stewart B, Wild C.: World Cancer Report 2014.
Published online. Int Agency Res Cancer. 2014,
[3] Akhtar SS, Reyes LM: Cancer in Al-Qassim, Saudi
Arabia: A retrospective study (1987-1995). Ann Saudi
Med. Published online. 1997, 10.5144/0256-
4947.1997.595
[4] General Authority for statistics. Establishments Census
2010. (2010). Accessed: July 2020:
https://saudicensus.sa/en/content/establishments-census-
2010.
[5] Saudi Health council. Cancer incidence report in. Saudi
Arabia. 2015. Saudi, 2015:10-17.
10.1145/3132847.3132886
[6] Al-Madouj, Eldali, & Al-Zahrani: Ten Year Cancer
Incidence among Nationals of the GCC States (1998-
2007). Gulf Center for Cancer Control and Prevention
(GCCCP). 2011, 113-131.
[7] World Health Organization - Cancer Fact Sheets. (2018).
Accessed: July 2020: https://www.who.int/news-
room/fact-sheets/detail/cancer.
[8] Cao LZ, Peng XD, Xie JP, Yang FH, Wen HL, Li S: The
relationship between iodine intake and the risk of thyroid
cancer. Med (United States). Published online. 2017.
10.1097/MD.0000000000006734
[9] Ilic M, Ilic I: Epidemiology of pancreatic cancer. World J
Gastroenterol. Published online. 2016,
10.3748/wjg.v22.i44.9694
[10] Rawla P, Barsouk A.: Epidemiology of gastric cancer:
Global trends, risk factors and prevention. Prz
Gastroenterol. 2019., 14:26-38. 10.5114/pg.2018.80001
[11] Alberg AJ, Brock M V., Ford JG, Samet JM, Spivack
SD. : Epidemiology of lung cancer: Diagnosis and
management of lung cancer, 3rd ed: American College of
Chest Physicians evidence-based clinical practice
guidelines. Chest. 2013, 143:10.1378/chest.12-2345
[12] Ba Saleem HO, Bawazir AA, Moore M, Al-Sakkaf KA:
Five years cancer incidence in Aden cancer registry,
Yemen (2002-2006). Asian Pacific J Cancer Prev. 2010,
11:507-511.
[13] Jamal S, Moghal S, Mamoon N, et al.: The pattern of
malignant tumours: Tumour registry data analysis, AFIP,
Rawalpindi, Pakistan (1992-2001). J Pak Med Assoc.
Published online. 2006, 56:
[14] Ghafoor M, Schuyten R, Bener A: Epidemiology of
Prostate Cancer in United Arab Emirates. Med J
Malaysia. Published online. 2003, 58:712-716.
[15] Rawla P.: Epidemiology of Prostate Cancer. World J
Oncol. 2019, 10:63-89. 10.14740/wjon1191
... The increased use of imaging modalities, followed by subsequent invasive testing, has led to a rise in the incidence and prevalence of thyroid cancer globally [1,2]. Epidemiological studies report a higher incidence of thyroid cancer in high-income regions, including North America and Europe. ...
Article
Full-text available
Background The global incidence of thyroid cancer has increased significantly over the past decades. This study aims to review the clinical characteristics and treatment outcomes of thyroid cancer at the Tertiary Care Hospital in the Najran region of Saudi Arabia. Material and methods We conducted a retrospective study of 279 patients diagnosed with thyroid cancer at our hospital from March 2014 to December 2021. Clinicopathologic parameters were obtained from the patient's medical records and examined using univariate and multivariate Cox regression to identify independent predictive markers. Result The mean age was 42.8 ±14.5 years, and most cases were female (n= 203, 72.8%). Most cases (n=170, 60.9%) underwent total thyroidectomy. Additionally, lymph node dissection was performed in 28 (10.0%) cases. Localized disease, distant, and regional metastasis were observed in 214 (76.7%), 34 (12.2%), and 31 (11.1%), respectively. The neck lymph nodes and lungs were the most common metastasis regions in 19 (6.8%) and 11 (3.9%) cases, respectively. Papillary thyroid cancer and follicular thyroid cancers accounted for the majority of cases in 236 (84.6%) and 33 (11.8%), respectively. Adjuvant therapy, including radioactive iodine ablation, was reported in 51 (18.3%) and external beam radiotherapy in four (1.4%). Independent prognostic factors of overall mortality of thyroid carcinoma were older age (Hazard ratio (HR):1.05, 95% confidence interval (CI): 1.01-1.09, p=0.008), Diabetic mellitus (HR: 4.30, 95% CI: 1.11-16.62, p=0.035), pathologic subtype of follicular carcinoma (HR: 4.48, 95% CI: 1.07-18.73, p=0.040) or non-papillary thyroid carcinoma subtypes (HR: 12.56, 95% CI: 2.44-64.74, p=0.002), metastasis presentation (HR: 11.70, 95% CI: 3.30-41.46, p<0.001), pulmonary metastasis (HR: 27.92, 95% CI: 6.96-111.98, p<0.001), bone and liver metastasis (HR: 15.20, 95% CI: 1.70-135.98, p=0.015), tumor size >4 cm (HR:121.21, 95% CI: 15.33- 958.34, p<0.001), and extrathyroidal extension (HR: 6.15, 95% CI: 1.59-23.77, p=0.009). Conclusion This study demonstrates that advanced age, the presence of diabetes, non-papillary thyroid carcinoma subtypes, metastatic disease, tumor size greater than 4 cm, and extrathyroidal extension are independently associated with a poorer prognosis in patients with thyroid carcinoma. To offer the finest modern care, a multidisciplinary approach should be employed when developing a tailored treatment strategy, considering relevant recommendations and stratification systems.
... p < 0.001) were found to be statistically significant factors. However, hypertension was not associated with COVID-19 in our cohort, possibly due to epidemiological variables related to cancer prevalence [23]. These findings align with previous research, which has established that hypertension, diabetes, cardiovascular disease, respiratory illness, and cancer are associated with an elevated risk of death in COVID-19 cancer patients [6,22]. ...
Article
Full-text available
Background The COVID-19 pandemic significantly impacted healthcare systems globally, with cancer patients representing a particularly vulnerable group. This study aims to evaluate the influence of COVID-19 on cancer, focusing on infection rates, types of care, therapy adjustments, and factors associated with COVID-19 infection. Materials and methods This single-center retrospective analysis included adult cancer patients who underwent anticancer therapy at King Khalid Hospital in Najran, Saudi Arabia, from December 20, 2020, to January 23, 2022. Data on patient and cancer characteristics, COVID-19 specifics, treatment delays, outcomes, and factors associated with COVID-19 were collected and analyzed. Results A total of 257 chemotherapy recipients were interviewed. The mean age was 52.6 ± 14.4 years, with 44 (17.1%) over 65 years old. Females comprised 160 (62.3%) of the patients. The most common malignancies were gastrointestinal (71, 27.6%), breast (70, 27.2%), and hematological (50, 19.5%). Metastasis was present in 116 patients (45.1%). Common comorbidities included diabetes (68, 26.5%) and hypertension (55, 21.4%). Most patients (226, 87.9%) were vaccinated against COVID-19. COVID-19 tested positive in 22 patients (8.6%), with a lower infection rate in vaccinated patients (7 vs. 15, p < 0.001). Most cases were mild (18,81.8%), with fever (19, 7.4%) and cough and fatigue (17, 6.6%) being the most common symptoms. The median time to resume treatment post-infection was 30 days. Factors associated with higher infection rates included diabetes (OR: 4.73, 95% CI: 1.94-12.03, p = 0.001), coronary artery disease (OR: 4.13, 95% CI: 1.07- 13.30, p = 0.049), chronic lung disease (OR: 15.58, 95% CI: 5.37-45.79, p < 0.001), chronic liver disease (OR:7.64, 95% CI: 2.38-22.98, p < 0.001), and multiple comorbidities (OR: 2.04, 95% CI: 1.46-2.90, p < 0.001),cancer patients who received chemotherapy (OR: 1.02, 95% CI: 0.12-12.79, p = 0.027), and immunotherapy (OR: 3.37, 95% CI:1.27-8.43, p = 0.012). Conclusion The incidence of COVID-19 in cancer patients is proportional to the prevalence in the general population of similar geographic areas. Diabetes, coronary artery disease, chronic lung disease, chronic liver disease, receiving chemotherapy or immunotherapy, and multiple comorbidities were associated with higher COVID- 19 infection rates.
... Our study indicated more prevalence of cancer in females (69%) than males (31%) and this is similar to the National Saudi Cancer registry data where the females (53.8%) while the males (46.2%) [11]. Further older age is having more prevalence than comparing to young age and which is also align with the previous study reported in Saudi Arabia [12]. ...
Article
Introduction: There is a substantial rise in the incidence of cancer in Saudi Arabia. The aim of this study was conducted to determine the demographic, prevalence, and pattern of cancer in the Northern Border region of Saudi Arabia-Arar. Methods: The record of 88 histologically confirmed cancer cases was retrieved and studied from files of the oncology department, Prince Abdul-Aziz Ibn Musaad hospital, Arar, Kingdom of Saudi Arabia (KSA). Results: The most common cancers in the whole population irrespective of sex were carcinoma of the leukemia, breast, lymphoma and leukemia combined and colorectal cancer. The most common cancers in females in Northern Border region were those of the breast, thyroid, and lymphomas and leukemia combined. Comparative findings for males were lymphomas and leukemias combined colorectal cancers. Conclusion: The present study showed a high prevalence and pattern of cancer in Northern Border region, Saudi Arabia according to gender, age, frequency, and type of cancer.
... However, such a case is not well accepted in the Arab population, as discrepancies and false-positive results and detection are on the rise [20] Due to this, generalized cut-off values for PSA screening have not yet been established [4] and tissue biopsy is still considered the standard of care for the definitive diagnosis of prostate cancer. Tissue biopsy is a costly procedure, and not all hospitals are capable of offering and performing such procedures [9] Another study revealed that Americans and other white population with PSA levels of >10 ng/mL present with higher risks of developing prostate cancer, in comparison to the Arab people, that most of the time, a PSA level of >10 ng/mL presents with Benign Prostatic Hyperplasia (BPH) with subclinical prostatitis, rather than definitive detection of prostate cancer [21] With such, the PSA level's specificity to detect the presence of ongoing prostatic cancer is still in question among the Arab population [4] Age-specific reference ranges of PSA in Arabs: In 2003, age-and population-specific reference range for PSA in Saudi nationals had been established [22] In such a reference range, men aged 40 to 89 years old are found to have normal PSA levels. However, in a study made to Kuwaiti and Omani men in 2005 revealed that the reason for attaining normal PSA levels is that Saudi nationals have innate lower PSA levels due to smaller prostate volume compared to those of white population, and is the same with more of the Asian community [23,29]. ...
Article
Full-text available
Background: Despite advances in treatment, pancreatic cancer frequently has a low survival rate due to its advanced-stage diagnosis. Treatment focuses on prolonging survival and maintaining quality of life. This study investigates the characteristics associated with survival in advanced pancreatic cancer patients treated at a single academic cancer center in Najran, Saudi Arabia. Method: A retrospective chart review study covering the period January 1, 2015, and December 31, 2023, involved 80 adult patients with pathologically confirmed pancreatic cancer (ductal adenocarcinoma) at King Khalid Hospital in Najran, Saudi Arabia. Clinicopathological characteristics, therapy, response, and survival outcomes were all gathered and analyzed. The chi-squared test, Kaplan-Meier, and Cox proportional hazards method with hazard ratios (HR) and 95% confidence intervals (CI) were used for statistical analysis. Result: The mean age was 65.7±14.1 years and 54 (67.5%) cases were male. The main symptom was abdominal pain (n=54, 67.5%), while jaundice was presented in 17 (21.2%) of cases. The baseline serum carbohydrate antigen 19-9 (CA 19-9) level varied among cases, with 35 (43.8%) having normal levels. The majority of cases (n=59, 73.8%) had distant metastases at the initial presentation, while 12 cases (15%) had localized disease (resectable), and 22 (27.5%) were locally advanced at the first presentation. The most commonly reported pathologic grade was poorly differentiated ductal adenocarcinoma in 39 (48.8%). FOLFIRINOX was used as first-line chemotherapy in 54 (67.5%) cases, while gemcitabine alone was used in 15 (18.8%) cases. First-line chemotherapy resulted in progressive disease in 30 (37.5%), stable disease in 30 (37.5%), and partial response in 14 (17.5%). With a mean follow‐up time of 14.8±8.6 months, 57 (71.2%) were dead, where the main cause of death was disease progression (n=51, 89.5%). The median overall survival was 13.5 months, with a 12-month survival rate of 56% and a 36-month survival rate of 17%. The median cancer-specific survival was 16 months (95% CI: 13-22 months). The 12-month median cancer-specific survival was 61% (95% CI: 51-73%), and the 36-month median cancer-specific survival was 19% (95% CI: 10-34%). In univariate analysis, initial metastasis presentation (HR: 35.46; 95% CI: 4.90-256.83, p<0.001), poor Eastern Cooperative Oncology Group Performance Status (ECOG-PS) (3-4) (HR: 2.34; 95% CI:1.34-4.09, p=0.003), and presence of multiple metastases (HR: 1.33; 95% CI: 1.09-1.62, p=0.004) were associated with worsened survival. Patients who received the first chemotherapy were associated with better survival (HR: 0.53; 95% CI: 0.29-0.98, p=0.043). Furthermore, the response rate in patients who received FOLFIRINOX was better than that of those who received gemcitabine alone, which was statistically significant (p=0.002). Conclusion: Our study showed that initial metastatic presentation, poor ECOG-PS, and the occurrence of numerous metastases were all linked with poor survival of patients with pancreatic adenocarcinoma. Additionally, FOLFIRINOX as a first-line treatment showed better survival rates than gemcitabine alone. Raising awareness among healthcare providers on the alarming signs of pancreatic cancer and the introduction of personalized oncology might improve the outcome of this fatal malignancy.
Article
Full-text available
Background: The aim of this paper is to compare the patterns and determinants of cancer mortality in Najran region before and after the COVID-19 epidemics. The association between cancer mortality and each of age, sex, site of cancer, stage, and the 30-days survival rate after the last dose of chemotherapy were assessed. Materials & Methods Adult cancer patients who died of cancer in King Khalid Hospital in Najran Saudi Arabia, were included in this retrospective observational study. We compared mortality patterns in a period of 6 months in 2020 (March to August) with the corresponding period of 2019. Results 50 dead adult cancer patients were included, 24 in 2019 and 26 in 2020. Among them, 21% vs 42% were younger than 65 years of age; 61% vs 62% were males, for the years 2019 & 2020 respectively. The top three killers in 2019 were colorectal, gastro-esophageal cancers, and hepatocellular carcinoma, while in 2020 were colorectal, hepatocellular carcinoma, and lymphomas. About 16.7% of patients died within 30 days of receiving anti-cancer treatment in 2019 in comparison with 7.7% in 2020. The difference in the 30-days mortality after receiving anti-cancer treatment was not statistically significant between 2019 and 2020 (p=0.329). Conclusion The Year 2020, the time of the COVID-19pandemic, was not associated with a significant increase in short-term mortality among patients with malignancy in Najran, Saudi Arabia. Our results generally reflect the crucial role of strict preventive national measures in saving lives and warrants further exploration.
Article
Full-text available
Prostate cancer is the second most frequent cancer diagnosis made in men and the fifth leading cause of death worldwide. Prostate cancer may be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. Based on GLOBOCAN 2018 estimates, 1,276,106 new cases of prostate cancer were reported worldwide in 2018, with higher prevalence in the developed countries. Differences in the incidence rates worldwide reflect differences in the use of diagnostic testing. Prostate cancer incidence and mortality rates are strongly related to the age with the highest incidence being seen in elderly men (> 65 years of age). African-American men have the highest incidence rates and more aggressive type of prostate cancer compared to White men. There is no evidence yet on how to prevent prostate cancer; however, it is possible to lower the risk by limiting high-fat foods, increasing the intake of vegetables and fruits and performing more exercise. Screening is highly recommended at age 45 for men with familial history and African-American men. Up-to-date statistics on prostate cancer occurrence and outcomes along with a better understanding of the etiology and causative risk factors are essential for the primary prevention of this disease.
Article
Full-text available
Gastric cancer remains one of the most common and deadly cancers worldwide, especially among older males. Based on GLOBOCAN 2018 data, stomach cancer is the 5th most common neoplasm and the 3rd most deadly cancer, with an estimated 783,000 deaths in 2018. Gastric cancer incidence and mortality are highly variable by region and highly dependent on diet and Helicobacter pylori infection. While strides in preventing and treating H. pylori infection have decreased the overall incidence of gastric cancer, they have also contributed to an increase in the incidence of cardia gastric cancer, a rare subtype of the neoplasm that has grown 7-fold in the past decades. A better understanding of the etiology and risk factors of the disease can help reach a consensus in approaching H. pylori infection. Dietary modification, smoking cessation, and exercise hold promise in preventing gastric cancer, while genetic testing is enabling earlier diagnosis and thus greater survival.
Article
Full-text available
Cancer of the pancreas remains one of the deadliest cancer types. Based on the GLOBOCAN 2012 estimates, pancreatic cancer causes more than 331000 deaths per year, ranking as the seventh leading cause of cancer death in both sexes together. Globally, about 338000 people had pancreatic cancer in 2012, making it the 11th most common cancer. The highest incidence and mortality rates of pancreatic cancer are found in developed countries. Trends for pancreatic cancer incidence and mortality varied considerably in the world. A known cause of pancreatic cancer is tobacco smoking. This risk factor is likely to explain some of the international variations and gender differences. The overall five-year survival rate is about 6% (ranges from 2% to 9%), but this vary very small between developed and developing countries. To date, the causes of pancreatic cancer are still insufficiently known, although certain risk factors have been identified, such as smoking, obesity, genetics, diabetes, diet, inactivity. There are no current screening recommendations for pancreatic cancer, so primary prevention is of utmost importance. A better understanding of the etiology and identifying the risk factors is essential for the primary prevention of this disease.
Article
Full-text available
To evaluate the magnitude of prostate cancer in the United Arab Emirates (UAE). A descriptive retrospective study. Tawam and Al-Ain Teaching Hospitals, Al-Ain Medical District, UAE. Subjects: Analysis based on patient admissions into the main referral teaching hospital, categorizing age, nationality groups and type of cancer. All prostate cancer patients, diagnosed and treated at Tawam and Al-Ain Hospitals during the period from 1982 to 2000, are included in the study and consisted of 84 subjects. The study series consisted of 84 patients with the ages ranging from 38 to 81 years with a median age of 56 years and a mean and standard deviation of 56.5 +/- 12.5 years. The study revealed that majority of the patients (n = 33, 39.2%) were diagnosed between 51 to 60 years of age. The majority of our patients were UAE nationals (44.0%), followed by patients from neighboring countries i.e. Oman, Yemen, Syria, Jordan and Egypt (40.5%). The initial pathological diagnosis was confirmed mainly by Trucut Needle Biopsy in the majority of patients (n = 48, 57%), TURP (n = 15, 18%), Open Prostatectomy (n = 4, 5%) and others i.e. lymph node, bone marrow, and pleural biopsies and high PSA (n = 17, 20%). The majority of our patients (77.7%) presented with an advanced disease and received hormonal treatment while 16.6% received radical radiotherapy and 5.5% had radical prostatectomy. According to our analysis the annual incidence of prostate cancer is 4.5/100,000 male population. The prevalence of prostatic carcinoma in the UAE, like other Arabian Gulf and Asian countries, is very low compared to Western Countries despite the high intake of calories and consumption of animal fat. However, genetics and environmental factors believed to be involved in the complex etiology of prostate cancer in UAE are not clear yet, and awaiting investigation.
Article
Full-text available
To provide information regarding frequency of malignant tumours through data retrieved from pathology based tumour registry of AFIP, Rawalpindi, Pakistan. All malignant tumours recorded with the AFIP tumour registry over a period of 10 years (1992-2001) were analysed in terms of age group, gender and type of tumour with relation to site. A comparison with the previously published material from same setting, national and international studies were also done. The total malignant tumours in the 10 years period were 21,168. Out of these, 12584 (59.5%) were seen in male patients while 8584 (40.5%) were in females. Total malignant tumours in pediatric age group were 927 (4.4%). The common malignant tumours in males in order of decreasing frequency were, those of prostate, skin, lymph node, leukaemia, urinary bladder, colorectum, bone, lung, stomach and liver. In females, breast carcinoma was on top followed by skin, leukaemia, ovary, coloretum, lymph node, bone, liver, cervix and gall bladder. In females, contrary to the Western studies and India, ovarian tumours were more frequent than cervical cancers. Comparison of this analysis with our previous analysis, national and international studies showed some interesting features. It was found that in males, tumours of the prostate were the most frequent as compared to the previous study, which showed lymphomas and leukemias to be the most common. On the other hand in females, tumours of the breast remained to be consistently most frequent.
Article
Full-text available
Regional differences in the pattern of cancer are obvious in Saudi Arabia. From January 1987 to December 1995, 1106 new cases of cancer (642 males, 464 females) were seen at the King Fahd Specialist Hospital in Buraidah, Al-Qassim. Overall, lymphomas, non-Hodgkin's and Hodgkin's disease combined were the most common malignancy seen (15.10%), followed by esophageal carcinoma (7.77%). Thyroid cancer was the most common malignancy among females (12.50%), followed by breast cancer (9.48%). The majority of the patients were in the younger age group (77% were <50 years of age). Among the hematological malignancies, acute lymphoblastic leukemia was the most frequent type (36.23%). Lymphomas were the most common malignancy (66.12%) seen in the pediatric age group (0-14 years), followed by leukemias and brain tumors. The pattern of cancer in Al-Qassim is generally similar to other regions of Saudi Arabia, with few regional variations. prominent among such variations is the high frequency of non-Hodgkin's lymphomas (NHL), esophageal and thyroid carcinomas.
Global Cancer Incidence and Mortality Rates and Trends--An Update: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • L A Torre
  • R L Siegel
  • E M Ward
Torre L. A., Siegel R. L., Ward E. M., et al.: Global Cancer Incidence and Mortality Rates and Trends--An Update: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cancer Epidemiology Biomarkers & Prevention. 2016, 25:16-27.
  • B Stewart
  • C Wild
Stewart B, Wild C.: World Cancer Report 2014. Published online. Int Agency Res Cancer. 2014,
Saudi Health council. Cancer incidence report in. Saudi Arabia
Saudi Health council. Cancer incidence report in. Saudi Arabia. 2015. Saudi, 2015:10-17. 10.1145/3132847.3132886
Ten Year Cancer Incidence among Nationals of the GCC States (1998-2007). Gulf Center for Cancer Control and Prevention (GCCCP)
  • Al-Madouj
  • Eldali
  • Al-Zahrani
Al-Madouj, Eldali, & Al-Zahrani: Ten Year Cancer Incidence among Nationals of the GCC States (1998-2007). Gulf Center for Cancer Control and Prevention (GCCCP). 2011, 113-131.